Dr. William F. Regine, MD

Dr. Regine practices at Maryland Proton Treatment Center in Baltimore, Maryland.

Dr. Regine's NPI, 1104831957, was assigned on July 30, 2006. Dr. Regine holds Maryland license D0059557.

Dr. Regine's primary practice is Maryland Proton Treatment Center, at 850 W Baltimore St, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 369-5200.

Dr. Regine's primary practice is Maryland Proton Treatment Center in Baltimore, Maryland. Dr. Regine is also affiliated with University of Maryland Medical Center. The medical group on file is UM Community Medical Group. Dmand AI also links Dr. Regine to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Regine practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Regine's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Regine is licensed in Maryland.

CMS data shows 587 Medicare services from Dr. Regine across 12 procedure codes in 2024, for 172 Medicare patients. Medicare paid $241,969 for them.

CMS counts 172 Medicare patients who saw Dr. Regine in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Regine's median patient age at 59, with 46% women.

Dr. Regine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 77 papers to Dr. Regine, published from 2006 to 2024. 2023 was the busiest year, with 7. The most frequent topics are Pancreatic Neoplasms, Radiotherapy Planning, Computer-Assisted and Radiotherapy, Intensity-Modulated. Dr. Regine has published most often in Int J Radiat Oncol Biol Phys. Dr. Regine's most frequent co-authors are Jason Kyle Molitoris, MD, Steven Joel Feigenberg, MD and Charles Brian Simone, MD.

Dmand AI links Dr. Regine to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Intraductal Neoplasms and Pancreatic Neoplasms. University of Maryland, Baltimore sponsors the most, 2.

CMS Open Payments shows 52 general payments to Dr. Regine from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Varian Medical Systems, Inc. paid the most, $21,740.